𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

✍ Scribed by Esnaola, Nestor F.; Chaudhary, Uzair B.; O'Brien, Paul; Garrett-Mayer, Elizabeth; Camp, E. Ramsay; Thomas, Melanie B.; Cole, David J.; Montero, Alberto J.; Hoffman, Brenda J.; Romagnuolo, Joseph; Orwat, Kelly P.; Marshall, David T.


Book ID
123510789
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
349 KB
Volume
88
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.